©The Author(s) 2025.
World J Gastroenterol. Aug 7, 2025; 31(29): 104830
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.104830
Published online Aug 7, 2025. doi: 10.3748/wjg.v31.i29.104830
Table 1 Characterization and clinical-pathological assessment of participants of study
| Gender | n (%) |
| Male | 14 (48.1) |
| Female | 13 (51.9) |
| Age of polyposis diagnosis | Mean (minimum-maximum) |
| 51 (19-69) | |
| Polyposis type | |
| Classic polyposis | 2 (7.4) |
| Attenuated polyposis | 25 (92.6) |
| Age of first diagnosed tumor | Mean (minimum-maximum) |
| 51 (19-64) | |
| Primary diagnosed tumor site1 | |
| Colorectal | 13 (76.4) |
| Endometrium | 1 (5.9) |
| Breast | 1 (5.9) |
| Prostate | 1 (5.9) |
| Thyroid | 1 (5.9) |
| Age of second diagnosed tumor | Mean (minimum-maximum) |
| 59 (49-69) | |
| Second primary diagnosed tumor site | |
| Colorectal | 2 (11.8) |
| Breast | 1 (5.9) |
| Thyroid | 1 (5.9) |
| Status | |
| Alive, in follow-up | 26 (96.3) |
| Deceased | 1 (3.7) |
- Citation: dos Santos W, Pereira AS, Laureano T, de Andrade ES, Reis MT, Garcia FA, Campacci N, Melendez ME, Reis RM, Galvão HC, Palmero EI. Whole-exome sequencing identifies new pathogenic germline variants in patients with colorectal polyposis. World J Gastroenterol 2025; 31(29): 104830
- URL: https://www.wjgnet.com/1007-9327/full/v31/i29/104830.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i29.104830